This contrasts with an earlier study that reported cannabidivardin improved symptoms (anxiety behaviour not assessed) in Mecp2 null mice (Vigli et al., 2018), so it is possible that cannabinoid receptors may be relevant to anxiety in Rett syndrome. This evidence concerns the gene MECP2 and Rett syndrome.